Ravi Mehrotra, MD, DPhil
@ravimehro
Clinician Researcher| Preventing Cancer| Pathology| Spkr @Tedx| Alum @afmc_pune| @EmoryRollins| @UniOfYork| @Bruneluni| @ChipFoundation| @fredhutch| @ICGA_India
ID: 247581650
https://sph.emory.edu/faculty/profile/index.php?FID=ravi-mehrotra-10910 05-02-2011 03:14:47
6,6K Tweet
2,2K Followers
712 Following
🎉 Congratulations to the team behind this important work! 🌍 Highlighting the need for culturally sensitive communication to improve patient outcomes. #GlobalHealth #CancerCare OncoAlert Miriam Mutebi ASCO ESMO - Eur. Oncology Union for International #CancerControl doi:10.1001/jamanetworkopen.2024.31128
Worrisome trend from the US. The Lancet Oncology covers the possible treasons for a near flat uptake of the vaccine since COVID-19, carrying my quotes along with other experts.
In many countries, prostate cancer is the most common malignancy in males. Learn how to reduce your risk and diagnose early. Dario Trapani Yüksel Ürün MANOJ KALITA Peter Sasieni CHIP India
Agree. Yüksel Ürün - With increasing number of senior citizens all around the world, appropriate assessment should be a top priority- often overlooked.
Cabinet approves #AyushmanBharat #PMJAY for 70 plus age group; 6 crore beneficiaries to be covered. Financial outlay Rs 3437 crore National Health Authority (NHA)
Important study Yüksel Ürün
There's a critical need to improve access to cancer testing, especially among lower-educated and rural women in India. Efforts to reduce barriers like lack of awareness, education, and infrastructure will be pivotal in closing this health gap. Raj Shankar Ghosh Yüksel Ürün Stand Up To Cancer
Exactly Dr. Sonali Vaid You nailed it. Even the expanded aayushman Bharat scheme will not cover preventive cancer and health checks - the need often hour! Vandana Mahajan CHIP India Cancer Prevention Research